Prevention for LongevityInstitutionIntelligenceStandardWorkAboutDiscuss an opportunity

Evidence Explorer · EV-001

ACCESS

CMS describes a ten-year model, rolling start dates, outcome-aligned payments, public reporting of aggregated risk-adjusted results, physician clinical oversight, clinical and data safeguards, and lifestyle/behavioral, diagnostic, medication, care-coordination, and technology-supported services.

Primary/authoritativeCurrentFederal model design2026-07-20

What this evidence supports

CMS describes a ten-year model, rolling start dates, outcome-aligned payments, public reporting of aggregated risk-adjusted results, physician clinical oversight, clinical and data safeguards, and lifestyle/behavioral, diagnostic, medication, care-coordination, and technology-supported services.

What it does not establish

The model is ongoing. Its design does not establish participant-specific effectiveness, final participation, coverage for every service, or future outcomes.

Answer-ready summary

CMS describes a ten-year model, rolling start dates, outcome-aligned payments, public reporting of aggregated risk-adjusted results, physician clinical oversight, clinical and data safeguards, and lifestyle/behavioral, diagnostic, medication, care-coordination, and technology-supported services.

Record details

Decision priority
Watch
Current status
Current
Evidence tracks
Payment/economics · Implementation/adoption
Source authority
Primary/authoritative
Source organization
CMS Innovation Center
Evidence design
Federal model design
Applicability
Applicable to decisions about the stated program, policy, standard, or development context; not evidence of clinical benefit beyond the cited scope.
Confidence for the stated claim
High
Freshness
Current
Record date
2026-07-20
Source updated
2026-08-17
Last verified
2026-09-03
Review due
2026-10-03 or sooner if the cited source changes.
Version
1.0

Evidence record fields

Claim supported
CMS describes a ten-year model, rolling start dates, outcome-aligned payments, public reporting of aggregated risk-adjusted results, physician clinical oversight, clinical and data safeguards, and lifestyle/behavioral, diagnostic, medication, care-coordination, and technology-supported services.
Source type and design
Federal model design
Population and setting
Not a participant-level clinical-study population in this source type. The program, policy, regulatory, standards, or research context described by the cited source.
Intervention/exposure and comparator
Not evaluated as a comparative intervention or exposure in the cited administrative or program source. No comparator is reported for this source-bounded claim.
Outcome or endpoint
The program, policy, regulatory, standards, or development state stated in the claim supported; no clinical outcome is inferred.
Follow-up duration
No clinical follow-up duration is reported for this source-bounded claim.
Effect estimate and uncertainty
No clinical effect estimate is reported. No statistical uncertainty estimate is reported; uncertainty is bounded through the source scope and stated limitations.
Harms/adverse events
No harms or adverse-event analysis is reported for this source-bounded administrative or program claim.
Missing data and attrition
Not reported; this record does not analyze participant-level data. Not applicable or not reported; no longitudinal participant cohort is analyzed.
Bias/limitations
The model is ongoing. Its design does not establish participant-specific effectiveness, final participation, coverage for every service, or future outcomes.
Applicability/generalizability
Applicable to decisions about the stated program, policy, standard, or development context; not evidence of clinical benefit beyond the cited scope.
Funding/conflicts
Funding or sponsorship is recorded only where the cited source and claim state it; otherwise it is not assessed in this record. No conflict-of-interest assessment is reported for this administrative or program-source record.
Replication or corroboration
The administrative or program claim is anchored to the cited authoritative source; independent clinical replication is not implied.
Decision use
Use as source-bounded context for Health-system leaders, Payers/employers, Clinicians, Policymakers, Public/patients; do not use as stand-alone evidence of safety, efficacy, coverage, endorsement, or scaled adoption.
Last reviewed / review due
Last reviewed 2026-09-03; review due 2026-10-03 or sooner if the cited source changes.

For this decision

Health-system leaders · Payers/employers · Clinicians · Policymakers · Public/patients

Primary sources

Related intelligence